HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

503.547

+4.3840.88%

Number of Gainers:16

Number of Losers:15

Number of Flat:2

PE:- -

High:506.514

Open:499.115

Low:485.417

Close:499.163

Volume:88.56M

Turnover:2.42B

Market Cap:318.37B

Float Cap:285.02B

Loading ...

Should Eli Lilly Drug Deal Require Action From InnoCare Pharma (SEHK:9969) Investors?

Simply Wall St.

BASECARE-B (02170) Spends HK$18,800 to Repurchase 15,000 Shares on October 9

Contec Medical Systems Secures Medical Device Registration Certificate for Color Doppler Ultrasound Diagnostic System

BASECARE-B (02170) Plans to Buy Back H-Shares for Up to RMB 5 Million

GF Securities Starts CStone Pharmaceuticals at Buy with HK$11.56 Price Target

MT Newswires Live

Suzhou Basecare Medical - Company to Repurchase H Shares for up to RMB5 Mln Under Repurchase Mandate

THOMSON REUTERS

Baiyunshan's Tianxin Pharmaceutical Secures NMPA Drug Registration Certificate for Irbesartan Hydrochlorothiazide Tablets

Antengene-B Spends HK$803,500 to Buy Back 254,500 Shares on October 9

Ascentage Pharma: A Dancer on the High Wire

Everest Medicines (SEHK:1952) Forms ESG Committee, Is The Stock 32% Undervalued?

Simply Wall St.

Asian Market Insights: Autostreets Development And 2 Other Promising Penny Stocks

Simply Wall St.

Antengene to Present New Preclinical Data for Autoimmune Drug Candidate ATG-207 at ACR 2026

Everest Medicines Appoints Ex-Moderna Executive Lakshmi Srinivasan as Head of Translational Medicine

Everest Medicines Opens Up Over 5%, Appoints Two Moderna Oncology Vaccine Scientists to Accelerate Global mRNA Clinical Development

Everest Medicines Welcomes Two Top mRNA Experts to Accelerate Global Innovation Strategy

InnoCare Pharma (SEHK:9969) Stock Dropped, So What Is Driving Attention Now?

Simply Wall St.

BRII-B Issues 7.258 Million Share Options and 1.3895 Million Restricted Share Units

GenFleet-B (02595) Spends HK$3.83 Million to Buy Back 135,000 Shares on October 8

Zhongsheng Pharmaceutical's Class 1 Innovative Drug RAY1225 Injection Achieves Topline Analysis Results in Phase III Weight Loss Clinical Trial

RemeGen Repurchases 60,000 Shares Through September

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hkg.itiger.com/stock/BK1574/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":503.54697,"timestamp":1791533285939,"preClose":499.16254,"halted":0,"volume":88563853,"delay":0,"changeRate":0.008784,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":4.38443,"latestTime":"10-09 16:00:00","open":499.1151,"high":506.514,"low":485.4165,"amount":2424699550.5,"amplitude":0.042266,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791768600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1791509400000,1791518400000],[1791522000000,1791532800000]],"pbRate":3.755372,"peRate":166.986761,"turnoverRate":0.003327,"increases":12,"decrements":18,"flats":2,"marketCap":318372953744,"floatMarketCap":285015092496},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":506.514,"amplitude":0.042266,"preClose":499.16254,"low":485.4165,"pbRate":"3.755372","latestPrice":503.54697,"volume":88563853,"delay":0,"open":499.1151,"prevYearClose":556.26263,"prevWeekClose":515.56,"prevMonthClose":532.388,"prevQuarterClose":532.388,"fiveDayClose":515.56,"twentyDayClose":496.758,"sixtyDayClose":525.824,"secType":"PLATE","market":"HK","turnoverRate":0.003327,"peRate":166.986761,"marketCap":318372953744,"floatMarketCap":285015092496,"timestamp":1791533285939,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":16,"down":15,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674862996","title":"Should Eli Lilly Drug Deal Require Action From InnoCare Pharma (SEHK:9969) Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2674862996","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674862996?lang=en_us&edition=fundamental","pubTime":"2026-10-10 02:24","pubTimestamp":1791570264,"startTime":"0","endTime":"0","summary":"InnoCare Pharma announced a research collaboration and license agreement with Eli Lilly to pursue up to five drug targets addressing critical unmet medical needs.\nThe Eli Lilly partnership provides external validation for InnoCare Pharma's late stage pipeline, with potential implications for future commercialization and cash flow mix.\nThis article examines how InnoCare Pharma's investment narrative is shaped by the Eli Lilly collaboration around up to five targets.\n\nScan how the Eli Lilly...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/should-eli-lilly-drug-deal-require-action-from-innocare-phar","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/should-eli-lilly-drug-deal-require-action-from-innocare-phar","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VOTE","09969","BK1574","DECU","FEBU","ISBC","JOYT","GXDW","RGLO","VGFPF","BK4211","PMDE","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164755503","title":"BASECARE-B (02170) Spends HK$18,800 to Repurchase 15,000 Shares on October 9","url":"https://stock-news.laohu8.com/highlight/detail?id=1164755503","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164755503?lang=en_us&edition=fundamental","pubTime":"2026-10-09 22:10","pubTimestamp":1791555021,"startTime":"0","endTime":"0","summary":"BASECARE-B (02170) issued an announcement that on October 9, 2026, it spent HK$18,800 to repurchase 15,000 shares.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02170","BK1222","BK1574","BK1597"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119313877","title":"Contec Medical Systems Secures Medical Device Registration Certificate for Color Doppler Ultrasound Diagnostic System","url":"https://stock-news.laohu8.com/highlight/detail?id=1119313877","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119313877?lang=en_us&edition=fundamental","pubTime":"2026-10-09 19:00","pubTimestamp":1791543614,"startTime":"0","endTime":"0","summary":"Contec Medical Systems Co.,Ltd. (300869.SZ) has announced that the company recently obtained a Medical Device Registration Certificate of the People's Republic of China issued by the Hebei Provincial...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300869","AGNG","HART","MEDX","IEIH","159883","PTH","MDEV","RSPH","BK0251","BK1583","BK1574","GDOC","09996","BK1100","LNGR","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193035517","title":"BASECARE-B (02170) Plans to Buy Back H-Shares for Up to RMB 5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1193035517","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193035517?lang=en_us&edition=fundamental","pubTime":"2026-10-09 18:47","pubTimestamp":1791542856,"startTime":"0","endTime":"0","summary":"BASECARE-B (02170) has announced that its board of directors is pleased to declare its intention to exercise its powers under the buyback mandate, and the company will from time to time repurchase...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1597","02170","BK1222","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674559728","title":"GF Securities Starts CStone Pharmaceuticals at Buy with HK$11.56 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2674559728","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674559728?lang=en_us&edition=fundamental","pubTime":"2026-10-09 18:44","pubTimestamp":1791542660,"startTime":"0","endTime":"0","summary":"GF Securities Starts CStone Pharmaceuticals at Buy with HK$11.56 Price Target","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","02616","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674855573","title":"Suzhou Basecare Medical - Company to Repurchase H Shares for up to RMB5 Mln Under Repurchase Mandate","url":"https://stock-news.laohu8.com/highlight/detail?id=2674855573","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674855573?lang=en_us&edition=fundamental","pubTime":"2026-10-09 18:40","pubTimestamp":1791542435,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nFWN45V0Y5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1597","02170","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188530342","title":"Baiyunshan's Tianxin Pharmaceutical Secures NMPA Drug Registration Certificate for Irbesartan Hydrochlorothiazide Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=1188530342","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188530342?lang=en_us&edition=fundamental","pubTime":"2026-10-09 18:00","pubTimestamp":1791540015,"startTime":"0","endTime":"0","summary":"Baiyunshan (ASX: 00874) has announced that its controlling subsidiary, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. (\"Tianxin Pharmaceutical\"), recently received a Drug Registration...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","01477","BK0196","BK1574","BK0096","BK0028","BK1515","BK1191","BK0012","BK1606","BK0175","600332","BK1521","BK0183","BK0070","BK0239","BK1197","00874","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107984410","title":"Antengene-B Spends HK$803,500 to Buy Back 254,500 Shares on October 9","url":"https://stock-news.laohu8.com/highlight/detail?id=1107984410","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107984410?lang=en_us&edition=fundamental","pubTime":"2026-10-09 17:46","pubTimestamp":1791539214,"startTime":"0","endTime":"0","summary":"Antengene-B (06996) announced that the company repurchased 254,500 shares on October 9, 2026, for a total of HK$803,500, at a price range of HK$3.07 to HK$3.27 per share.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1191","BK1574","06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172839647","title":"Ascentage Pharma: A Dancer on the High Wire","url":"https://stock-news.laohu8.com/highlight/detail?id=1172839647","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172839647?lang=en_us&edition=fundamental","pubTime":"2026-10-09 14:21","pubTimestamp":1791526895,"startTime":"0","endTime":"0","summary":"Based on publicly available information. This is for informational exchange only and does not constitute any investment advice.Innovative drug development is a business of trading time for...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06855","BK4139","BK1161","AAPG","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674835130","title":"Everest Medicines (SEHK:1952) Forms ESG Committee, Is The Stock 32% Undervalued?","url":"https://stock-news.laohu8.com/highlight/detail?id=2674835130","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674835130?lang=en_us&edition=fundamental","pubTime":"2026-10-09 12:42","pubTimestamp":1791520924,"startTime":"0","endTime":"0","summary":"Everest Medicines ESG committee announcement\nEverest Medicines (SEHK:1952) has created a new Environmental, Social and Governance Committee, with four board members appointed and Yifang Wu named chair. This move places formal oversight of ESG topics on the company's governance agenda.\nInvestors have seen Everest Medicines’ share price fall 12.83% over the past 30 days and 24.01% year to date, while the 1 year total shareholder return is down 48.57%. This suggests that recent ESG initiatives...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1952/everest-medicines-shares/news/everest-medicines-sehk1952-forms-esg-committee-is-the-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1952/everest-medicines-shares/news/everest-medicines-sehk1952-forms-esg-committee-is-the-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MDCO","PRXI","BK1574","01952","BK1583","IVRA","BK1161","ESG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674836010","title":"Asian Market Insights: Autostreets Development And 2 Other Promising Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2674836010","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674836010?lang=en_us&edition=fundamental","pubTime":"2026-10-09 12:04","pubTimestamp":1791518688,"startTime":"0","endTime":"0","summary":"Amidst a backdrop of mixed signals from global markets, the Asian stock landscape continues to capture investor attention with its unique blend of challenges and opportunities. As investors navigate this complex environment, penny stocks—though often considered relics of past market eras—remain relevant due to their potential for growth and value. These smaller or newer companies can offer compelling opportunities, especially when backed by strong financials, making them intriguing candidates...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/2055000-choice2-card/1788949255437","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/2055000-choice2-card/1788949255437"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/cn/materials/shse-600725/yunnan-yunwei-shares/news/asian-market-insights-autostreets-development-and-2-other-pr","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/cn/materials/shse-600725/yunnan-yunwei-shares/news/asian-market-insights-autostreets-development-and-2-other-pr","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["03681","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674882752","title":"Antengene to Present New Preclinical Data for Autoimmune Drug Candidate ATG-207 at ACR 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2674882752","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674882752?lang=en_us&edition=fundamental","pubTime":"2026-10-09 10:48","pubTimestamp":1791514139,"startTime":"0","endTime":"0","summary":"Antengene to present new preclinical data for autoimmune drug candidate ATG-207 at ACR 2026Antengene flagged new preclinical results for ATG-207, an experimental autoimmune therapy, for presentation a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nNDLc6Mss5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","06996","BK1191","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674049884","title":"Everest Medicines Appoints Ex-Moderna Executive Lakshmi Srinivasan as Head of Translational Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2674049884","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674049884?lang=en_us&edition=fundamental","pubTime":"2026-10-09 10:13","pubTimestamp":1791512025,"startTime":"0","endTime":"0","summary":"Everest Medicines appoints ex-Moderna executive Lakshmi Srinivasan as head of translational medicineEverest Medicines appointed Lakshmi Srinivasan as senior vice president, head of translational medic","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nNDL9xdVL5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","GNOM","MRNX","BK4568","BK4551","BK1161","MRNY","BK4534","WDNA","BK1574","BK4548","BK4532","BK4501","01952","BK1583","LGHT","MRNA","BK4585","IDNA","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186550774","title":"Everest Medicines Opens Up Over 5%, Appoints Two Moderna Oncology Vaccine Scientists to Accelerate Global mRNA Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1186550774","media":"Deep News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186550774?lang=en_us&edition=fundamental","pubTime":"2026-10-09 09:51","pubTimestamp":1791510682,"startTime":"0","endTime":"0","summary":"Everest Medicines (01952) opened up over 5% in early trading. As of press time, the stock was up 2.22% at HK$29.44, with a turnover of HK$34.801 million.On October 9, Everest Medicines announced the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952","BK1583","BK1574","BK1161","159646"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104033904","title":"Everest Medicines Welcomes Two Top mRNA Experts to Accelerate Global Innovation Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=1104033904","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104033904?lang=en_us&edition=fundamental","pubTime":"2026-10-09 09:00","pubTimestamp":1791507631,"startTime":"0","endTime":"0","summary":"On October 9, Everest Medicines (01952) announced the appointment of Dr. Lakshmi Srinivasan as Senior Vice President and Head of Translational Medicine, and Dr. Brandon Coder as Vice President of...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01952","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674042020","title":"InnoCare Pharma (SEHK:9969) Stock Dropped, So What Is Driving Attention Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2674042020","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674042020?lang=en_us&edition=fundamental","pubTime":"2026-10-08 23:35","pubTimestamp":1791473706,"startTime":"0","endTime":"0","summary":"InnoCare Pharma (SEHK:9969) drew fresh attention after announcing a research collaboration and license agreement with Eli Lilly to develop new medicines, including potential eligibility for up to US$3.35b in combined upfront and milestone payments.\nFor investors watching the tape, InnoCare Pharma’s share price has come under pressure, with a 7-day share price return down 15.21% and a 30-day share price return down 15.04%. At the same time, the 3-year total shareholder return remains up...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/innocare-pharma-sehk9969-stock-dropped-so-what-is-driving-at","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/innocare-pharma-sehk9969-stock-dropped-so-what-is-driving-at","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1574","09969","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131087931","title":"BRII-B Issues 7.258 Million Share Options and 1.3895 Million Restricted Share Units","url":"https://stock-news.laohu8.com/highlight/detail?id=1131087931","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131087931?lang=en_us&edition=fundamental","pubTime":"2026-10-08 22:21","pubTimestamp":1791469279,"startTime":"0","endTime":"0","summary":"On October 8, 2026, the Company granted a total of 7.258 million share options to 63 option grantees under the terms of the 2023 Share Option Scheme, subject to acceptance by the option grantees,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1574","02137","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186524088","title":"GenFleet-B (02595) Spends HK$3.83 Million to Buy Back 135,000 Shares on October 8","url":"https://stock-news.laohu8.com/highlight/detail?id=1186524088","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186524088?lang=en_us&edition=fundamental","pubTime":"2026-10-08 19:48","pubTimestamp":1791460092,"startTime":"0","endTime":"0","summary":"GenFleet-B (02595) announced that on October 8, 2026, it spent HK$3.8307 million to repurchase 135,000 shares.The company disclosed the share repurchase in a filing.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02595","BK1515","159938","BK1574","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158567840","title":"Zhongsheng Pharmaceutical's Class 1 Innovative Drug RAY1225 Injection Achieves Topline Analysis Results in Phase III Weight Loss Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1158567840","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158567840?lang=en_us&edition=fundamental","pubTime":"2026-10-08 19:40","pubTimestamp":1791459618,"startTime":"0","endTime":"0","summary":"Guangdong Zhongsheng Pharmaceutical Co.,Ltd. (002317.SZ) has announced that its controlled subsidiary, Guangdong Zhongsheng Ruichuang Biotechnology Co., Ltd., has obtained topline analysis data from...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002317","BK1574","LNGR","BMED","BK0239","PSYK","IBBJ","159992","BK1161","MDTX","06978","BK0188","MEDX","IBBQ","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189523975","title":"RemeGen Repurchases 60,000 Shares Through September","url":"https://stock-news.laohu8.com/highlight/detail?id=1189523975","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189523975?lang=en_us&edition=fundamental","pubTime":"2026-10-08 17:28","pubTimestamp":1791451702,"startTime":"0","endTime":"0","summary":"RemeGen (09995) announced that, as of September 30, 2026, the company had cumulatively repurchased 60,000 of its own shares through the centralized bidding trading method via the Shanghai Stock...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995","BK0239","LU1969619763.USD","LU2488822045.USD","LU1064130708.USD","688331","LU1064131003.USD","LU2328871848.SGD","BK1583","BK1161","BK1574","LU2148510915.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":1,"totalSize":146,"code":"91000000","status":"200"}]}}